Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 47,459 | 46,435 | 43,190 | 41,873 | 45,784 |
| Cost of Goods | 18,045 | 16,667 | 19,317 | 18,051 | 19,616 |
| Gross Profit | 29,414 | 29,768 | 23,873 | 23,822 | 26,168 |
| Operating Expenses | 63,296 | 63,067 | 71,508 | 72,635 | 97,852 |
| Operating Income | -33,837 | -32,632 | -47,318 | -48,762 | -71,068 |
| Interest Expense | 2,952 | 2,939 | 2,696 | 2,993 | 3,012 |
| Other Income | 3,072 | 3,474 | 3,766 | 4,222 | 4,613 |
| Pre-tax Income | -33,717 | -32,097 | -46,248 | -47,533 | -69,467 |
| Net Income Continuous | -33,717 | -32,097 | -46,248 | -47,533 | -69,467 |
| Minority Interests | -25 | -26 | -26 | -26 | -26 |
| Net Income | $-33,692 | $-32,071 | $-46,222 | $-47,507 | $-69,441 |
| EPS Basic Total Ops | -0.22 | -0.22 | -0.31 | -0.33 | -0.48 |
| EPS Basic Continuous Ops | -0.23 | -0.22 | -0.31 | -0.33 | -0.48 |
| EPS Diluted Total Ops | -0.22 | -0.22 | -0.31 | -0.33 | -0.48 |
| EPS Diluted Continuous Ops | -0.23 | -0.22 | -0.31 | -0.33 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.22 | -0.26 | N/A | N/A |
| EBITDA(a) | $-30,847 | $-30,049 | $-44,414 | $-46,191 | $-68,635 |